Advertisement

Picture BIO Deutschland Corona Special Germany 2020 650x80px

Deals > All

Total search results: 10281 | Ordered by Date (descending)
next pagenext page 1 2 3 ... 100 101 102 103  next pagenext page

order ascendingorder descendingDeal: Collaboration or Financing order ascendingorder descendingDate
Talecris Biotherapeutics–Grifols: investment, 2010 acquisition $3b 2010-01-01
Univ Bielefeld–Illumina: DNA sequencing system, 2010 supply existent GA IIx sequencing system at ITT Biotech 2010-01-01
Univ Bielefeld–Roche: DNA sequencing system, 2010 supply existent GS 454 sequencing system at ITT Biotech 2010-01-01
Univ Freiburg–Scienion: print/spotting technology, 2010H1 supply existent use of sciFLEXARRAYER for printing polysaccharide microarrays 2010-01-01
Baxter–3B Pharmaceuticals: peptide therapeutics, 2009– collab developm for hemophilia taken over from Jerini 2009-12-31
Dräger–Siemens: investment, 200912 DIVESTMENT of remaining 25% in Dräger Medical AG to Drägerwerk AG for at least €250m with €175m in cash 2009-12-29
Novexel–AstraZeneca: investment, 200912 acquisition 100% $350m in cash at closing + $75m milestones 2009-12-23
Chattem–Sanofi-Aventis: investment, 200912–201003 acquisition $1.9b 2009-12-21
LipoFIT–SEVERAL: investment, 200912 1st financing round €4m from SHS + KfW + Bayern Kapital 2009-12-21
Leibniz-Gemeinschaft–Evotec: drug screening, 200912– service by European ScreeningPort for anti-malaria drug develop to Bernhard Nocht Institute 2009-12-17
Leibniz-Gemeinschaft–Hamburg (govt): grant, 200912 grant €400k from City of Hamburg for anti-malaria drug development to BNI 2009-12-17
ExonHit–Alize RP: public relations, 200912 service existent 2009-12-16
Molecular Partners–SEVERAL: investment, 200912 financing round Series B CHF46m=€30m new + lead investor Essex Woodlands Health Ventures 2009-12-15
Hepa Wash–SEVERAL: investment, 200912 financing round Series A €3.8m private investors + KfW 2009-12-06
Argenx–BioGeneration Ventures: investment, 200912 financing round Series A totalling €12.5m incl co-investor BioGeneration Ventures 2009-12-03
Argenx–Crédit Agricole: investment, 200912 financing round Series A totalling €12.5m incl co-investor Crédit Agricole Private Equity 2009-12-03
Argenx–Erasmus MC Biomedical Fund: investment, 200912 financing round Series A totalling €12.5m incl returning co-investor Erasmus MC Biomedical Fund 2009-12-03
Argenx–Forbion: investment, 200912 financing round Series A totalling €12.5m incl co-lead investor Forbion Capital Partners 2009-12-03
Argenx–KBC: investment, 200912 financing round Series A totalling €12.5m incl co-investor KBC Private Equity 2009-12-03
Argenx–Life Sciences Partners: investment, 200912 financing round Series A totalling €12.5m incl co-lead investor LSP 2009-12-03
Argenx–SEVERAL: investment, 200912 financing round Series A €12.5m in two closings 2009-12-03
Argenx–Thuja Capital: investment, 200912 financing round Series A totalling €12.5m incl returning co-investor Thuja Capital Healthcare Fund 2009-12-03
Argenx–VIB: investment, 200912 financing round Series A totalling €12.5m incl co-investor Flanders Interuniversity Institute VIB 2009-12-03
Inagen–SEVERAL: investment, 200912 seed financing round DKK5m from Novo A/S + CAT 2009-12-01
Mologen–SEVERAL: investment, 200912–201001 capital increase €3.58m 512k new shares €7/share to institutional investors 2009-12-01
Movetis–SEVERAL: investment, 200912 IPO €12.25/share NYSE Euronext Brussels 2009-12-01
Pfizer–Protalix: taliglucerase alfa, 200912– license excl ww $60m upfront + $55m milestones + revenue/expense sharing 2009-12-01
Selah Technologies–Lab21: investment, 200912 acquisition + renamed Lab21 Inc 2009-12-01
SureChem–Macmillan: investment, 200912 acquisition 2009-12-01
KeyNeurotek–Evotec: analytical services, 200911– collab co-marketing of specific toxicological analyses European ScreeningPort 2009-11-25
Univ Kiel– Evotec: analytical services, 200911– service by European ScreeningPort for Zentrum für Integrative Psychiatrie 2009-11-25
Clovis Oncology–Clavis Pharma: CP-4126, 200911– license milestones ww development + commercialisation $15m upfront + $365m + royalties 2009-11-24
Kreatech–SEVERAL: investment, 200911 financing round €2m existing investor LSP + Alafi Capital + a new investor 2009-11-18
Abbott–PanGenetics: PG110, 200911 acquisition of global rights to PG110 for €170m upfront + €20m milestones 2009-11-12
Bayer–MicroDiscovery: bioinformatics, 201010– collab extension 1y Bayer Schering Pharma AG 2009-11-12
BioVex–SEVERAL: investment, 201011 financing round Series F 2nd closing €30m 2009-11-10
ACE Biosciences–Zymenex: investment, 200911 acquisition 2009-11-09
Boehringer–Evotec: drug discovery services, 200911– collab research + license extension + expansion 4y to incl oncology targets 2009-11-09
Photonion–Airsense Analytics: investment, 200911 co-founding of Photonion GmbH by Airsense Analytics GmbH 2009-11-09
Photonion–Helmholtz: investment, 200911 share acquisition by Ascenion GmbH 2009-11-09
Photonion–Helmholtz: mass spectrometry, 200911 license excl to photoionisation mass spec technology from Helmholtz Zentrum München 2009-11-09
Photonion–Tofwerk: investment, 200911 co-founding of Photonion GmbH by Tofwerk AG 2009-11-09
Acino–Arpida: iclaprim, 200911 acquisition CHF2.1m of all assets related to iclaprim by Acino Holding AG 2009-11-04
Takeda–Domain Therapeutics: DTect-All technology, 200911 supply service existent use of DTect-All to discover GPCR-targeting drug candidates 2009-11-04
Cevec–SEVERAL: investment, 200911 financing round €4m lead investors Creathor Venture Fonds + NRW.BANK 2009-11-03
Probiodrug–Bellevue: investment, 200911 financing round Series B totalling €36m incl new + lead investors BB Biotech + EdRIP 2009-11-02
Probiodrug–Biogen Idec: investment, 200911 financing round Series B totalling €36m incl new + co-investor Biogen Idec New Ventures 2009-11-02
Probiodrug–LCF Rothschild: investment, 200911 financing round Series B totalling €36m incl new + lead investors BB Biotech + EdRIP 2009-11-02
Probiodrug–Life Sciences Partners: investment, 200911 financing round Series B totalling €36m incl new + co-investor LSP 2009-11-02
Evotec–OTHER: investment, 200911–201103 delisting from Nasdaq 2009-11-01
Kompass–Bremen (govt): grant, 200911–201010 grant €226k for developm of PCR test for joint infections from WFB within RnD Innovation Programme 2009-11-01
Phytolutions–Bremen (govt): grant, 200911–201110 grant €120k for pilot project algae biofuel production from WFB Bremen within PFAU programme 2009-11-01
Amsterdam Molecular–Progenika: DNAchip technology, 200910– collab developm + commercialisation agreem for LPLchip companion diagnostic to Glybera 2009-10-29
Promethera–SEVERAL: investment, 200910 financing round Series A €5.3m lead investor Vesalius Biocapital 2009-10-29
Promethera–Vesalius Biocapital: investment, 200910 financing round Series A totalling €5.3m incl lead investor Vesalius 2009-10-29
Bender MedSystems–eBioscience: investment, 200910 acquisition in cash 2009-10-27
Biocartis–Advent Venture Partners: investment, 200910 financing round Series A totalling €10m incl co-investor Advent Venture Partners 2009-10-15
Biocartis–Aescap Venture: investment, 200910 financing round Series A totalling €10m incl lead investor Aescap Venture 2009-10-15
Biocartis–Benaruca: investment, 200910 financing round Series A totalling €10m incl returning co-investor Benaruca 2009-10-15
Biocartis–Biovest (BE): investment, 200910 financing round Series A totalling €10m incl co-investor Biovest 2009-10-15
Biocartis–KBC: investment, 200910 financing round Series A totalling €10m incl co-investor KBC Private Equity 2009-10-15
Integrated Diagnostics–SEVERAL: investment, 200910 financing round Series A 1st $10m tranche of $30m InterWest Partners + Wellcome Trust + Hopp 2009-10-14
GSK–Prosensa: RNA-based drugs, 200910–201401 collab excl ww GBP16m upfront + GBP412m milestones + royalties developm for DMD TERMINATED 1/14 2009-10-13
Bicycle Therapeutics–Atlas Venture: investment, 200910 seed financing from Atlas Venture + Novartis Venture Fund 2009-10-06
Bicycle Therapeutics–Novartis: investment, 200910 seed financing from Atlas Venture + Novartis Venture Fund 2009-10-06
Bicycle Therapeutics–SEVERAL: investment, 200910 seed financing from Atlas Venture + Novartis Venture Fund 2009-10-06
ChemBioTec network (DE)–SeSaM-Biotech: industrial biotechnology, 200910– collab SeSaM becomes project partner of ChemBioTec 2009-10-01
Fovea–Sanofi-Aventis: investment, 200910 acquisition up to €370m incl upfront payment + milestones 2009-10-01
SeSaM-Biotech–Germany (govt): grant, 200910– grant from BMBF for SesaM-Biotech within Biokatalyse2021 Cluster 2009-10-01
EBEWE Arzneimitel–Novartis: investment, 200909 acquisition $1.3b EBEWE specialty generic injectable business by Sandoz 2009-09-24
Inverness Medical–Mobidiag: molecular diagnostics, 200909– distribution in Germany by Inverness Medical Deutschland GmbH 2009-09-09
Biosolutions (GR)–Ionicon: PTR mass spectrometer, 200909– distribution in Greece + Cyprus by Biosolutions Ltd 2009-09-07
Bayer–Algeta: radium-223 chloride, 200909– collab developm Alpharadin + ww commercialisation rights up to €560m + royalties incl €42.5m upfront 2009-09-03
Endosense (St. Jude Medical)–Ysios Capital: investment, 2009 Series B financing of Endosense by Ysios Capital Partners 2009-09-02
Alizé Pharma–Andrew Lloyd Associates: public relations, 200909 service existent 2009-09-01
Alizé Pharma–SEVERAL: investment, 200909 financing round €3m new + lead investor SHAM + existing investors Octalfa + CEMA 2009-09-01
Biotest–Biotecon: Hygiene Screening System, 200909– collab ww sale by Biotest Business Unit Microbiology 2009-09-01
Hayhurst Media–Schwartz Communications: investment, 200908 acquisition 2009-08-18
PerkinElmer–Max Planck: silicon photomultiplier technology, 200908– license excl from Max Planck Innovation for SiPM developed by MPI-MPP + MEPhI 2009-08-18
Cambridge Biostability–Nova Laboratories: investment, 200908 acquisition of assets of Cambridge Biostability Ltd by Nova Labs 2009-08-13
Saarland Univ–GeneBio: SmileMS s/w, 200908– supply + collab SmileMS used w Thermo LXQ to create LC-MS mass spectral library by Prof H Maurer 2009-08-01
Univ London–Thermo Fisher: lab automation equipment, 200907 supply Kingfisher Flex system to new ICR proteomics lab 2009-07-20
Univ London–Thermo Fisher: mass spectrometer, 200907 supply TSQ Vantage triple quad system to new ICR proteomics lab 2009-07-20
Univ London–Thermo Fisher: mass spectrometer, 200907 supply UK’s first two LTQ Orbitrap Velos systems to new ICR proteomics lab 2009-07-20
BIOKÉ–Cell Signaling Technology: investment, 200907 acquisition 100% of BIOKÉ BV + renamed Cell Signaling Technology Europe BV 2009-07-09
NatuTec–eBioscience: investment, 200907 acquisition of NatuTec GmbH by eBioscience Inc 2009-07-01
Symetis–SEVERAL: investment, 200906 financing round CHF23m co-led by Wellington Partners + Vinci Capital 2009-06-29
Evotec–Cellectricon: Dynaflow system, 200906 supply purchase Dynaflow electrophysiology system for ion channel screening by Evotec 2009-06-24
Evotec–MDS: cell analysis technology, 200906 supply existent use of IonWorks Quattro + PatchXpress for ion channel screening by Evotec 2009-06-24
Evotec–Nanion: cell analysis technology, 200906 supply existent use of Patchliner + Port-a-Patch systems for ion channel screening by Evotec 2009-06-24
Evotec–Sophion: QPatch system, 200906 supply purchase Q-Patch electrophysiology platform for ion channel screening by Evotec 2009-06-24
Grifols–Fundació Clínic for Biomedical Research: human albumin, 200906– collab to develop albumin for liver cirrhosis incl funding €2m from Grifols 2009-06-11
Decision News Media–William Reed: investment, 200906 acquisition by William Reed Business Media 2009-06-04
Eufets–BioNTech: investment, 200906 acquisition by BioNTech AG 2009-06-01
Korea Basic Science Institute–Australian National Univ: mass spectrometer, 200906 supply installation SHRIMP IIe HR-SIMS from ASI 2009-06-01
IDM–Takeda: investment, 200905– acquisition $2.64/share cash tender offer announced 2009-05-18
Max Planck–Inventive Capital: financial services, 200905 service development of DDC Ventures fund by MP Innovation + Inventive Capital Advisors LLP 2009-05-14
Max Planck–Life Sciences Partners: financial services, 200905– service management of DDC Ventures fund by LSP 2009-05-14
Panatecs–CovalX: mass spectrometry, 200905– supply Panatecs to offer MALDI-TOF proteomic services using High-Mass System from CovalX 2009-05-08
Renovis–Evotec: investment, 200905 DIVESTMENT shut down of Renovis + Evotec US operations 2009-05-05
next pagenext page 1 2 3 ... 100 101 102 103  next pagenext page



Advertisement

Picture Kentro Design Corporate and Web Design Berlin 650x65px

To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to info@iito.de and simply fill the subject line with the word »LSE Newsletter«

To get even more information, please take a look at our [gs] professional services offering and read the gene-sensor Product Flyer [PDF file]


Advertisement

Picture ConsulTech GmbH GDPR-compliant E-Col Home Office 650x80px

» top